Latest & greatest articles for menopause

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on menopause or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on menopause and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for menopause

1. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women?s Sexual Health

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women?s Sexual Health CONSENSUS RECOMMENDATIONS Managementofgenitourinarysyndromeofmenopauseinwomenwith orathighriskforbreastcancer:consensusrecommendationsfromThe North American Menopause Society and The International Society for the Study of Women’s Sexual Health Stephanie S (...) , CCD, NCMP, IF, FACOG, 14 Shari B. Goldfarb, MD, 15 and Sheryl A. Kingsberg, PhD 16 Abstract TheobjectiveofTheNorthAmericanMenopauseSociety(NAMS)andTheInternationalSocietyfortheStudyof Women’s Sexual Health (ISSWSH) Expert Consensus Panel was to create a point of care algorithm for treating genitourinary syndrome of menopause (GSM) in women with or at high risk for breast cancer. The consensus recommendationswillassisthealthcareprovidersinmanagingGSMwithagoalofimprovingthecareandqualityof life

2019 The North American Menopause Society

2. Treatments for reducing menopausal hot flushes are ranked for effectiveness

Treatments for reducing menopausal hot flushes are ranked for effectiveness Signal - Treatments for reducing menopausal hot flushes are ranked for effectiveness Dissemination Centre Discover Portal NIHR DC Discover Treatments for reducing menopausal hot flushes are ranked for effectiveness Published on 25 July 2017 A combination of oestrogen and progestogen via patches is the best treatment for menopause symptoms. Other options may be less beneficial, including tablets combining oestrogen (...) and progestogen, and non-hormonal treatments, isoflavones and black cohosh, though they may have other benefits. There is no evidence to support the use of antidepressants. Menopause affects women’s personal life and work life, but many don’t seek help from healthcare professionals. It is important to identify the most effective and safest treatment to help women in this transitional period. This review compared treatment options for the short-term management of hot flushes and night sweats in women aged 45

2019 NIHR Dissemination Centre

3. Effects of acute dietary nitrate supplementation on aortic blood pressures and pulse wave characteristics in post-menopausal women. (PubMed)

Effects of acute dietary nitrate supplementation on aortic blood pressures and pulse wave characteristics in post-menopausal women. 30668996 2019 02 18 1089-8611 85 2019 Jan 19 Nitric oxide : biology and chemistry Nitric Oxide Effects of acute dietary nitrate supplementation on aortic blood pressures and pulse wave characteristics in post-menopausal women. 10-16 S1089-8603(18)30213-1 10.1016/j.niox.2019.01.008 Consumption of nitrate-rich beetroot juice can lower blood pressure in peripheral (...) premenopausal women (22 ± 1 yr) served as a reference (non-supplemented) cohort. Brachial and derived-aortic variables showed the expected age-associated differences in these women (all p < 0.05). In post-menopausal women, nitrate supplementation reduced (p < 0.05 vs. placebo visit) brachial systolic BP (BR nitrate -4.9 ± 2.1 mmHg vs BR placebo +1.1 ± 1.8 mmHg), brachial mean BP (BR nitrate -4.1 ± 1.7 mmHg vs BR placebo +0.9 ± 1.3 mmHg), aortic systolic BP (BR nitrate -6.3 ± 2.0 mmHg vs BR placebo +0.5

2019 Nitric oxide : biology and chemistry

4. Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial

Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial 30222235 2018 10 24 1471-0528 2018 Sep 17 BJOG : an international journal of obstetrics and gynaecology BJOG Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial. 10.1111/1471-0528.15471 To assess the short- and long-term effects of mindfulness-based stress (...) reduction (MBSR) on the resulting quality of life, sexual functioning, and sexual distress after risk-reducing salpingo-oophorectomy (RRSO). Randomised controlled trial. A specialised family cancer clinic of the university medical center Groningen. Sixty-six women carriers of the BRCA1/2 mutation who developed at least two moderate-to-severe menopausal symptoms after RRSO. Women were randomised to an 8-week MBSR training programme or to care as usual (CAU). Change in the Menopause-Specific Quality

2018 EvidenceUpdates

5. Acupuncture for symptoms in menopause transition: a randomized controlled trial

Acupuncture for symptoms in menopause transition: a randomized controlled trial 30125529 2018 10 01 1097-6868 219 4 2018 Oct American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Acupuncture for symptoms in menopause transition: a randomized controlled trial. 373.e1-373.e10 S0002-9378(18)30672-0 10.1016/j.ajog.2018.08.019 Acupuncture has been used for women during menopause transition, but evidence is limited. We sought to evaluate the efficacy of electroacupuncture on relieving (...) symptoms of women during menopause transition. We conducted a prospective, multicenter, randomized, participant-blinded trial in China mainland. Subjects were randomized to receive 24 treatment sessions of electroacupuncture at traditional acupoints or sham electroacupuncture at nonacupoints over 8 weeks with 24 weeks' follow-up. Primary outcome was the change from baseline in the total score of Menopause Rating Scale at week 8. Secondary outcomes included the changes from baseline in the average 24

2018 EvidenceUpdates

6. Menopause

Menopause Menopause - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Menopause Last reviewed: August 2018 Last updated: September 2018 Summary The diagnosis is clinical, based on the absence of menses for 12 months, and does not require further testing for appropriately presenting patients. Oestrogen therapy is an effective treatment for the management of menopausal symptoms including hot flushes, night sweats (...) , and is unlikely to increase the risk of stroke or venous thrombosis above that of non-users. Non-hormonal interventions may help women who have a contraindication to, or cannot tolerate, HT. However, they are less effective than HT in controlling menopausal symptoms. Definition Onset of the menopause is heralded by the cessation of menses for at least 12 consecutive months, without some other reason for amenorrhoea (such as pregnancy, hormone therapy, or other medical condition). No further testing

2018 BMJ Best Practice

7. Menopause

Menopause Top results for menopause - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search (...) button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for menopause The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory

2018 Trip Latest and Greatest

8. Menopause

Menopause Autosynthesis - Trip Database or use your Google+ account Turning Research Into Practice My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search

2018 Trip Evidence Maps

9. Treatments for reducing menopausal hot flushes are ranked for effectiveness

Treatments for reducing menopausal hot flushes are ranked for effectiveness NIHR DC | Signal - Treatments for reducing menopausal hot flushes are ranked for effectiveness Dissemination Centre Discover Portal NIHR DC Discover NIHR Signal Treatments for reducing menopausal hot flushes are ranked for effectiveness Published on 25 July 2017 A combination of oestrogen and progestogen via patches is the best treatment for menopause symptoms. Other options may be less beneficial, including tablets (...) combining oestrogen and progestogen, and non-hormonal treatments, isoflavones and black cohosh, though they may have other benefits. There is no evidence to support the use of antidepressants. Menopause affects women’s personal life and work life, but many don’t seek help from healthcare professionals. It is important to identify the most effective and safest treatment to help women in this transitional period. This review compared treatment options for the short-term management of hot flushes and night

2018 NIHR Dissemination Centre

10. Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence

Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Copyright © 2018 Inc. All rights reserved. | | | | | | The content on this site is intended for health professionals. We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the . Advertisements on this site do not constitute a guarantee

2018 Society of Obstetricians and Gynaecologists of Canada

11. [Gender Features of Radical Oxidation of Lipids in Menopausal Women and Men in Andropause]. (PubMed)

[Gender Features of Radical Oxidation of Lipids in Menopausal Women and Men in Andropause]. 29297641 2018 02 20 2018 10 23 0869-6047 71 3 2016 Vestnik Rossiiskoi akademii meditsinskikh nauk Vestn. Akad. Med. Nauk SSSR [Gender Features of Radical Oxidation of Lipids in Menopausal Women and Men in Andropause]. 248-54 10.15690/vramn629 Our aim was to assess lipid peroxidation ― antioxidant protection in menopausal women and men in andropause and to compare these processes in different gender (...) and age groups. 74 women and 37 men were examined. This study was a prospective, randomized cohort study. Women were divided into perimenopausal group (n=22, mean age 49.03±3.13), postmenopausal group (n=15, mean age 54.43±4.54) and control (n=37, mean age 34±1.2). Men were divided into a group of andropause (n=20, mean age 50.38±2.63) and control (n=17, mean age 35.21±4.75). Body mass index in the main and control groups was comparable. Questionnaires, clinical examination, assessment of the lipid

Full Text available with Trip Pro

2018 Vestnik Rossiiskoi akademii meditsinskikh nauk

12. Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. (PubMed)

Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Hormone therapy (HT) was widely prescribed in the 1980s and 1990s and has been controversial since the initial results of the Women's Health Initiative (WHI) trial in the early 2000s suggested that it increased risk for breast cancer and coronary heart disease and did not prolong life. However, more recent data and reexamination of the WHI results suggest (...) that HT is safe and effective for many women when used around the time of menopause. Two experts debate the 2017 Hormone Therapy Position Statement of The North American Menopause Society, which recommends HT as first-line treatment of vasomotor symptoms, and apply it to the care of Ms. R, a 52-year-old woman with severe hot flashes, sleep disturbance, and irritability.

2018 Annals of Internal Medicine

13. Menopause

Menopause CLINICAL PROFESSIONAL RESOURCE Menopause RCN guidance for nurses, midwives and health visitors Endorsed by This publication is supported by industryMENOPAUSE 2 This publication is due for review in November 2020. To provide feedback on its contents or on your experience of using the publication, please email publications.feedback@rcn.org.uk Acknowledgements This new publication is based on, and replaces, previous RCN publications – Women’s Health and the Menopause: RCN Guidance (...) for Nurses, Midwives and Health Visitors (RCN, 2005 and 2014) and Complementary Approaches to Menopausal Symptoms: RCN Guidance for Nurses, Midwives and Health Visitors (RCN, 2006). The RCN Women’s Health Forum would like to thank the menopause project team for the development of this publication: Debra Holloway (project chair), Nurse Consultant Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust and Chair of the RCN Women’s Health Forum Carmel Bagness, RCN Professional Lead Midwifery and Women’s

2018 Royal College of Nursing

14. Menopause

Menopause Menopause - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Menopause Last reviewed: August 2018 Last updated: September 2018 Summary The diagnosis is clinical, based on the absence of menses for 12 months, and does not require further testing for appropriately presenting patients. Oestrogen therapy is an effective treatment for the management of menopausal symptoms including hot flushes, night sweats (...) , and is unlikely to increase the risk of stroke or venous thrombosis above that of non-users. Non-hormonal interventions may help women who have a contraindication to, or cannot tolerate, HT. However, they are less effective than HT in controlling menopausal symptoms. Definition Onset of the menopause is heralded by the cessation of menses for at least 12 consecutive months, without some other reason for amenorrhoea (such as pregnancy, hormone therapy, or other medical condition). No further testing

2018 BMJ Best Practice

15. Abnormal Uterine Bleeding in Pre-Menopausal Women

Abnormal Uterine Bleeding in Pre-Menopausal Women No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 5, Pages e391–e415 No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women x Sukhbir Singh , MD Ottawa, ON x Carolyn Best , MD Toronto, ON x Sheila Dunn , MD Toronto, ON x Nicholas Leyland , MD Toronto, ON x Wendy Lynn Wolfman , MD Toronto, ON No 292

2018 Society of Obstetricians and Gynaecologists of Canada

16. Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence

Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence No. 358-Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 4, Pages 503–511 No. 358-Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence x Jens-Erik Walter , MD Montréal, QC x Annick Larochelle (...) , MD Montréal, QC No. 358, April 2018 DOI: Figures Figure Comparative pre- and post-laser vaginal biopsies. Abstract Objective This technical bulletin reviews the evidence relating to risks and benefits of using intravaginal laser technology in the management of genitourinary syndrome of menopause and stress urinary incontinence. Intended Users Gynaecologists, urogynaecologists, urologists, and other health care professionals who assess, counsel, and provide care for women with genitourinary

2018 Society of Obstetricians and Gynaecologists of Canada

17. A review of effective herbal medicines in controlling menopausal symptoms (PubMed)

A review of effective herbal medicines in controlling menopausal symptoms Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir November 2017, Volume: 9, Issue: 11, Pages: 5826-5833, DOI: http://dx.doi.org/10.19082/5826 Corresponding author: Assistant Professor Dr. Roshanak Salari, Department of Clinical Persian Pharmacy, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Tel: +98.51338829279, Fax: Email: salarir@mums.ac.ir Received (...) of effective herbal medicines in controlling menopausal symptoms Rahele Kargozar 1 , Hoda Azizi 2 , Roshanak Salari 3 1 Ph.D. student of Persian Medicine, Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 2 M.D., Assistant Professor, Department of Chinese and Complementary Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 3 Ph.D. of Drug Control, Assistant Professor

Full Text available with Trip Pro

2017 Electronic physician

18. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. (PubMed)

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. BACKGROUND: No clinical trials have compared osteoporosis drugs with incident fractures as the primary outcome. We compared the anti-fracture efficacy of teriparatide with risedronate in patients with severe osteoporosis. METHODS: In this double-blind, double-dummy trial, we enrolled post-menopausal women with (...) compared with 61 (9·8%) of 680 in the risedronate group (hazard ratio 0·48, 95% CI 0·32-0·74; p=0·0009). Non-vertebral fragility fractures occurred in 25 (4·0%) patients in the teriparatide group and 38 (6·1%) in the risedronate group (hazard ratio 0·66; 95% CI 0·39-1·10; p=0·10). INTERPRETATION: Among post-menopausal women with severe osteoporosis, the risk of new vertebral and clinical fractures is significantly lower in patients receiving teriparatide than in those receiving risedronate. FUNDING

2017 Lancet

19. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. (PubMed)

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. Importance: Health outcomes from the Women's Health Initiative Estrogen Plus Progestin and Estrogen-Alone Trials have been reported, but previous publications have generally not focused on all-cause and cause-specific mortality. Objective: To examine total and cause-specific cumulative mortality, including during the intervention and extended postintervention follow

Full Text available with Trip Pro

2017 JAMA

20. Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study

Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study 28626058 2017 06 19 2017 07 25 1524-4628 48 8 2017 Aug Stroke Stroke Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study. 2266-2269 10.1161/STROKEAHA.117.017132 Double-blind randomized studies on the effects of oral postmenopausal hormone therapies were stopped mainly because of increased risk of stroke. We aimed to assess the risk of all strokes and various subtypes (...) 0039-2499 estrogen hormonal therapy ischemic stroke menopause stroke 2016 12 20 2017 05 04 2017 05 10 2017 6 20 6 0 2017 6 20 6 0 2017 6 20 6 0 ppublish 28626058 STROKEAHA.117.017132 10.1161/STROKEAHA.117.017132

Full Text available with Trip Pro

2017 EvidenceUpdates